Dr. Myat Phone Kyaw
Yangon, 11191, Burma
NCT Number: NCT03648411
A cross-sectional study will be conducted in selected 2 sentinel sites for assessment of drug resistance falciparum and vivax among asymptomatic infection in migrant workers in Myanmar.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Yangon, 11191, Burma
Although malaria prevalence is decreasing in Myanmar, drug resistance threatens the malaria elimination by 2030 especially high risk persons including migrant population. Previous study indicated that asymptomatic malaria parasite carried drug resistance gene such as K13 mutant that is genetically responsible for artemisinin resistant falciparum malaria. These asymptomatic carries may be a source to spread the disease and it is very important to conduct the surveillance on drug resistance status among high vulnerable persons. Unfortunately, there is no study to assess the drug resistance molecular markers in asymptomatic malaria among migrant workers in Myanmar. Therefore, this study fulfills the gaps of knowledge on important of asymptomatic hidden infection exploring to formulate the recommendation for elimination of malaria in Myanmar.
In this study, asymptomatic infections are screened by rapid diagnostic test, microscopy and molecular methods.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Proportion of the drug resistance molecular markers will be found-out and compared.
Time frame: 1 week
Number of the hidden malaria cases by RDT, microscopy or nested PCR (molecular method)
Time frame: 3 months
Among the asymptomatic cases, molecular markers will be analyzed (K13 and pfmdr1 copy number for falciparum and pvcrt-o, pvmdr1, pvdhps and pvdhfr gene analysis for vivax cases by Sanger Sequencing.
Department of Medical Research, Lower Myanmar
Other
Assessment of Drug Resistance Molecular Markers in Asymptomatic Malaria Among Migrant Workers in Myanmar
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05974267
Asymptomatic Diseases, Asymptomatic Infections
Ouagadougou, Burkina Faso
View Trial DetailsNCT05567016
Asymptomatic Diseases, Asymptomatic Infections
Bagamoyo, Tanzania
View Trial DetailsNCT07170098
Apical Periodontitis, Asymptomatic Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03754322
Asymptomatic Diseases, Asymptomatic Infections
Calgary, Alberta, Canada
View Trial Details